Physician profile
John D Corl
NPI 1790778595
$389,689.95
in general payments reported to CMS, 2019-2025
39 companies · $145K in 2025
The $145K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,024 · 2020: $7,734 · 2021: $31K · 2022: $68K · 2023: $53K · 2024: $77K · 2025: $145K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $165K · Travel and Lodging: $47K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $38K · Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $165,487.50 |
| Travel and Lodging | $47,330.48 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $37,950.00 |
| Food and Beverage | $15,910.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $242,649.89 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $109,141.40 | 2019-2025 | Perclose Prostyle, Esprit, Prostar |
| Cardinal Health 200 LLC | $6,389.07 | 2019 | |
| Boston Scientific Corporation | $5,721.71 | 2019-2025 | Ranger, Enroute Transcarotid Stent |
| Endologix LLC | $5,593.99 | 2023 | Torus Stent Graft System, Endocross Device |
| Cardiovascular Systems INC. | $5,187.11 | 2019-2021 | |
| Cordis US Corp. | $3,485.26 | 2022-2025 | Brite Tip, Mynx Control, Brite Tip Radianz |
| Reflow Medical INC | $3,063.07 | 2024-2025 | |
| Medtronic, INC. | $2,713.15 | 2021-2025 | Symplicity G3, Ffrangio, Onyx Frontier |
| Medtronic Vascular, INC. | $2,010.90 | 2019-2020 | |
| Inari Medical, INC. | $629.64 | 2019-2020 | |
| Limflow INC. | $614.17 | 2023 | Limflow System |
| Philips North America LLC | $563.56 | 2019-2025 | (6554) Peripheral Vascular Undivided, IV Other, Intrasight Mobile |
| Biotronik INC. | $258.53 | 2019-2023 | Orsiro Mission, Pk Papyrus, Recross |
| Novartis Pharmaceuticals Corporation | $182.38 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $181.90 | 2019-2023 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $181.51 | 2019-2022 | |
| Cook Medical LLC | $168.44 | 2022-2024 | Zilver Ptx |
| Penumbra, INC. | $151.92 | 2025 | Indigo System |
| Surmodics, INC. | $141.59 | 2024 | Pounce Thrombectomy, Pounce Lp Thrombectomy, Pounce Thrombectomy System |
| Janssen Pharmaceuticals, INC | $125.03 | 2019-2022 | |
| Kci USA, INC. | $108.03 | 2020 | |
| Imperative Care, INC | $100.31 | 2023 | Prodigy Catheter |
| Abiomed | $97.41 | 2023 | Impella |
| Abbvie INC. | $32.29 | 2025 | |
| Sanofi-Aventis U.S. LLC | $26.94 | 2019 | |
| Edwards Lifesciences Corporation | $19.78 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| W. L. Gore & Associates, INC. | $18.63 | 2019 | |
| Cleerly, INC. | $17.96 | 2023 | Cleerly Labs |
| Kiniksa Pharmaceuticals, Ltd. | $17.57 | 2022 | |
| Bardy Diagnostics, INC. | $15.02 | 2021 | |
| Amarin Pharma, INC. | $14.88 | 2019 | |
| Truvic Medical, INC. | $13.88 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.80 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.78 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.47 | 2021 | |
| Chiesi USA, INC. | $11.98 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$179,374.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Corl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.